• <em>Mucor germinans,</em> a novel dimorphic species resembling <em>Paracoccidioides</em> in a clinical sample: questions on ecological strategy
• A 46-year-old woman presenting with anterior mediastinal mass and superior vena cava obstruction syndrome
• A global perspective of the changing epidemiology of invasive fungal disease and real-world experience with the use of isavuconazole
• A multidisciplinary approach to mucormycosis
• A one-pot five component reaction for the synthesis of tetrazol-benzofuran hybrids and their inhibitory activity against <em>Mucor lusitanicus</em>
• A Rare Case of Coronavirus Disease 2019 Encephalitis Mimicking Creutzfeldt-Jacob Disease in an Immunocompromised Patient: A Case Report
• A Rare Case of Maxillary Mucormycosis in a Child With Juvenile Diabetes Mellitus
• A rare case of preseptal orbital mucormycosis in a kidney transplant recipient
• A rare case of pulmonary mucormycosis and broncho-esophageal fistula in a patient with poorly controlled diabetes
• A Retrospective Case Series Analysis of Pregnancy and COVID-19 Based on a Global Postmarketing COVID-19 Surveillance Program
• A Retrospective Study of Imaging of Invasive Rhino-Orbital-Cerebral Mucormycosis in the COVID-19 Pandemic in a Tertiary Care Center
• A Scoping Review on Complications in Modern Hair Transplantation: More than Just Splitting Hairs
• A Study on the Effect of Quaternization of Polyene Antibiotics' Structures on Their Activity, Toxicity, and Impact on Membrane Models
• Additional EBUS-guided intralesional amphotericin B injection combined systemic intravenous therapy in pulmonary mucormycosis: a case report
• Agreement between two real-time commercial PCR kits and an in-house real-time PCR for diagnosis of mucormycosis
• Alternative ergosterol biosynthetic pathways confer antifungal drug resistance in the human pathogens within the <em>Mucor</em> species complex
• An interesting report of COVID-19 associated mucormycosis (CAM) cases by two different species of Mucorales
• An update on pharmacotherapy for fungal infections in allogeneic stem cell transplant recipients
• Aspergillosis coinfection in patients with proven mucormycosis
• Bilateral Rhino-Orbital-Cerebral Mucormycosis
• Breaking the mold: Insights into the clinical management and outcomes of rhinocerebral mucormycosis in adults
• Case report: Disseminated mucormycosis misdiagnosed as malignancy developed from allergic bronchopulmonary mycosis caused by Rhizopus microsporus following SARS-CoV-2 infection in a woman
• Cerebritis, optic ischemia, and cavernous sinus thrombosis arising from sinonasal mucormycosis
• Characterisation of the spatio-temporal localisation of a pan-Mucorales specific antigen during germination and immunohistochemistry
• Clinical Characteristics and Prognosis of Patients with Acute Leukemia Complicated with Mucormycosis after Chemotherapy
• Clinical Characteristics, Prognosis Factors and Metagenomic Next-Generation Sequencing Diagnosis of Mucormycosis in patients With Hematologic Diseases
• Clinical features of pediatric mucormycosis: role of metagenomic next generation sequencing in diagnosis
• Colonic Mucormycosis in Fistulizing Crohn's Disease
• Comment on: Retrospective study of patient characteristics and treatment for mucormycosis in post-COVID-19 population
• Comparative evaluation of antifungal susceptibility testing methods for <em>Rhizopus</em> species isolates
• Comparison between abdominal CT findings in intensive care unit (ICU) and non-ICU patients with Covid-19: experience from a tertiary care hospital
• COVID-19-associated rhino-orbito-cerebral mucormycosis: a single center prospective study of 264 patients
• Cutaneous mucormycosis infection owing to Rhizomucor variabilis presenting as recurrent lower limb ulceration and cellulitis in a diabetic patient
• Diagnosis of mucormycosis from nasal swabs using commercial PCR platforms; a feasible alternative?
• Digitally Guided Advanced Prosthodontic Rehabilitation for Post-COVID-19 Mucormycosis Using Patient-Specific Implants: A Case Report
• Disseminated Cutaneous Mucormycosis Developing in Peristomal Pyoderma Gangrenosum
• Disseminated Mucormycosis and T-cell Depleted Allogeneic Stem Cell Transplantation - an unusual case study
• Diverse Clinical Manifestations and Challenges of Mucormycosis: Insights From Serial Cases
• Dual Donor-Derived Renal Allograft Mucormycosis From a Single Deceased Donor
• Evaluating the therapeutic potential of amygdalin: Cytotoxic and antimicrobial properties
• Exploring the feasibility of utilizing universal primers in detecting mucormycosis pathogens: An in-silico analysis
• Factors Impacting Outcome and Prognosis of Invasive Fungal Sinusitis: How Vital is Iron Metabolism?
• Factors Influencing Mortality in COVID-19-Associated Mucormycosis - The International ID-IRI Study
• Factors influencing mortality in COVID-19-associated mucormycosis: The international ID-IRI study
• Gastrointestinal mucormycosis presenting as melena in a patient with severe COVID 19
• Herpes simplex virus reactivation in patients of COVID-19-associated mucormycosis
• Idiopathic aplastic anemia with concurrent complications of colonic perforation and mucormycosis: Case report
• Impact of COVID-19 Disease on the Development of Osteomyelitis of Jaws: A Systematic Review
• Increased serum ferritin is associated with severity of orbital disease in COVID-19-associated rhino-orbito-cerebral mucormycosis: A quantitative analysis
• Intestinal mucormycosis as a differential diagnosis of small bowel ischemia
• Invasive Fungal Sinusitis and Its Orbital Morbidity in Pediatric Population: A Strategic Treatment Algorithm and Outcomes
• Investigating the Hepcidin Gene Polymorphisms in COVID-19-Associated Mucormycosis Susceptibility: A Clinical-Laboratory Study
• Letter to the editor: accuracy required in data entry when using machine learning techniques to predict risk of disease
• Maxillary Mucormycotic Osteonecrosis as a Manifestation of Post-COVID-19 Infection in Non-diabetic Patients: Report of Two Cases
• Mucorales: A systematic review to inform the World Health Organization priority list of fungal pathogens
• Mucormicosis: un dulce enemigo, serie de casos
• Mucormycosis during COVID-19 era: A retrospective assessment
• Mucormycosis in an Immunocompetent Patient Recovering From Dengue Fever
• Mucormycosis Masquerading as Gastric Tumor
• Mucormycosis Superinfection of a Chemical Burn
• Mucormycosis, the Black Fungus in the Post-COVID-19 Pandemic: A Case Report with Review of Literature
• Mucormycosis: A sweet enemy, case series
• Multicenter and multimodal imaging study reveals rare fundus lesions in patients after SARS-CoV-2 infection
• Myo5B plays a significant role in the hyphal growth and virulence of the human pathogenic fungus <em>Mucor lusitanicus</em>
• Nasal Septum Deviation in Patients with Acute Invasive Fungal Rhinosinusitis in a Tertiary Care Hospital: A Cross-Sectional Study
• New lineages of RNA viruses from clinical isolates of <em>Rhizopus microsporus</em> revealed by fragmented and primer-ligated dsRNA sequencing (FLDS) analysis
• Number of sinus procedures reduces inpatient mortality for invasive fungal rhinosinusitis
• Ocular manifestations of COVID-19
• Oral Isavuconazole Combined with Nebulized Inhalation and Bronchoscopic Administration of Amphotericin B for the Treatment of Pulmonary Mucormycosis: A Case Report and Literature Review
• Post-Coronavirus Disease-2019 Rhino-orbital Mucormycosis: A Case Report
• Post-dengue mucormycosis- a novel entity or COVID-19 associated in disguise?
• Primary Cutaneous Mucormycosis Confirmed by Molecular Testing in a Child With Acute Lymphoblastic Leukemia on Daily Imatinib
• Primary renal mucormycosis in a type 2 diabetic patient: A case report from Syria
• Proven Cutaneous Mucormycosis in a COVID-19 Patient: A Case Report and Literature Review
• Pulmonary mucormycosis as a presentation of COVID 19: Case series
• Pulmonary mucormycosis eroding the chest wall: challenges in the management
• Reconstruction of Nasal Deformity Resulting from Mucormycosis Using a Chin Silicone Implant
• Recurrent <em>Mucor indicus</em> central venous catheter infection in a five year old child on long term parenteral nutrition for short gut syndrome: could gut translocation be responsible?
• Rehabilitation of the Surgical Defect Secondary to Mucormycosis With a Definitive Obturator: A Case Report
• Renal Mucormycosis with Disseminated Lytic Bony Lesions
• Resurgence of orbital mucormycosis during COVID-19 pandemic: Study from a tertiary care center in Eastern India
• Rhino-orbital-cerebral mucormycosis caused by Rhizopus arrhizus diagnosis via metagenomics next-generation sequencing: a case report
• Rhinocerebral mucormycosis and Trichosporon asahii fungemia in a pediatric patient with acute lymphoblastic leukemia: a rare coinfection
• Rhinocerebral Mucormycosis in Patients with Kidney Disease Following Covid 19 Infection
• Risk Factors and Outcomes of Mucorales Infection in a Modern Cohort of Solid Organ Transplant, Hematopoietic Cell Transplant, and Chimeric Antigen Receptor T-cell Therapy Recipients
• Risk Factors of COVID-19 associated mucormycosis in Iranian patients: a multicenter study
• Secondary bacterial infections in post-COVID-19 mucormycosis cases: a retrospective study at Imam Khomeini Hospital Complex, March 2020-April 2021
• Simultaneous endobronchial and mediastinal mucormycosis in a patient with Diabetes Mellitus and SARS-CoV-2: A case report and literature review
• Sinus fungal balls caused by Syncephalastrum spp.: 2 clinical cases and literature review
• Successful Management of Pulmonary Mucormycosis Presenting as Round Pneumonia by Lung Resection in a Kidney Transplant Recipient
• Successful Treatment of Severe Aplastic Anemia with Hematopoietic Stem Cell Transplantation in the Setting of Active Mucormycosis
• Successful Treatment of Sternal Osteomyelitis and Mediastinitis Caused by Rhizopus Following Cardiac Surgery
• Surgical treatment of appendiceal mucormycosis in an immunocompromised patient: a case report
• Synergistic action of lactoferrin and its derived functional fragments as a promising therapeutic agent in combating mucormycosis
• Synergistic and potential antifungal properties of tailored, one pot multicomponent monoterpenes co-delivered with fluconazole encapsulated nanostructure lipid carrier
• The Comprehensive Management of Patients with Rhino-Orbito-Cerebral Mucormycosis; A Perspective from Antifungal Treatment to Prosthetic Rehabilitation: A Descriptive Cohort Study
• The Impact of Dimitrios P. Kontoyiannis on Mucormycosis Research
• To determine the role of transcutaneous retrobulbar amphotericin B in COVID-19-related rhino-orbital-cerebral mucormycosis
• Topical liposomal amphotericin B with surgical debridement in primary cutaneous mucormycosis
• WHO BREF Quality of Life Score as a Prognostic Indicator of Survival in Patients recovered from COVID-19 Associated Rhino-Orbito-Cerebral Mucormycosis